Valeant Just Cranked Up Its Offer For Allergan
REUTERS/ Shannon Stapleton
Valeant Pharmaceuticals just increased the cash portion of its offer to buy out Allergan.The company is now offering $58.30 in cash per share, up from a previous offer of $48.30.
It continues to offer 0.83 shares of Valeant for every share of Allergan.